Which has higher earnings & valuation, HQL or RVT?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Life Sciences Investors $198.93M 3.05 N/A N/A N/A Royce Small-Cap Trust $88.69M 24.44 N/A N/A N/A

Is HQL or RVT more profitable?

Company Net Margins Return on Equity Return on Assets abrdn Life Sciences Investors N/A N/A N/A Royce Small-Cap Trust N/A N/A N/A

Does the media refer more to HQL or RVT?

In the previous week, abrdn Life Sciences Investors had 3 more articles in the media than Royce Small-Cap Trust. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 1 mentions for Royce Small-Cap Trust. Royce Small-Cap Trust's average media sentiment score of 1.91 beat abrdn Life Sciences Investors' score of 1.07 indicating that Royce Small-Cap Trust is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment abrdn Life Sciences Investors 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Royce Small-Cap Trust 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable valuation and earnings, NUV or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nuveen Municipal Value Fund $104.26M 18.53 N/A N/A N/A abrdn Life Sciences Investors $198.93M 3.05 N/A N/A N/A

Is NUV or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Nuveen Municipal Value Fund N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Which has higher valuation & earnings, USA or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Liberty All-Star Equity Fund N/A N/A N/A N/A N/A abrdn Life Sciences Investors $198.93M 3.05 N/A N/A N/A

Is USA or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Liberty All-Star Equity Fund N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Does the media refer more to USA or HQL?

In the previous week, Liberty All-Star Equity Fund and Liberty All-Star Equity Fund both had 4 articles in the media. abrdn Life Sciences Investors' average media sentiment score of 1.07 beat Liberty All-Star Equity Fund's score of 0.71 indicating that abrdn Life Sciences Investors is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Liberty All-Star Equity Fund 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive abrdn Life Sciences Investors 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, HQL or GAB?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Life Sciences Investors $198.93M 3.05 N/A N/A N/A Gabelli Equity Trust $305.25M 5.81 N/A N/A N/A

Is HQL or GAB more profitable?

Company Net Margins Return on Equity Return on Assets abrdn Life Sciences Investors N/A N/A N/A Gabelli Equity Trust N/A N/A N/A

Does the media favor HQL or GAB?

In the previous week, abrdn Life Sciences Investors had 1 more articles in the media than Gabelli Equity Trust. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 3 mentions for Gabelli Equity Trust. abrdn Life Sciences Investors' average media sentiment score of 1.07 beat Gabelli Equity Trust's score of 0.49 indicating that abrdn Life Sciences Investors is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment abrdn Life Sciences Investors 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Gabelli Equity Trust 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, HQL or STEW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Life Sciences Investors $198.93M 3.05 N/A N/A N/A SRH Total Return Fund N/A N/A N/A N/A N/A

Is HQL or STEW more profitable?

Company Net Margins Return on Equity Return on Assets abrdn Life Sciences Investors N/A N/A N/A SRH Total Return Fund N/A N/A N/A

Does the media prefer HQL or STEW?

In the previous week, abrdn Life Sciences Investors had 2 more articles in the media than SRH Total Return Fund. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 2 mentions for SRH Total Return Fund. SRH Total Return Fund's average media sentiment score of 1.43 beat abrdn Life Sciences Investors' score of 1.07 indicating that SRH Total Return Fund is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment abrdn Life Sciences Investors 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SRH Total Return Fund 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

abrdn Life Sciences Investors (HQL) Competitors

$19.94 +0.02 (+0.10%)

As of 02:39 PM Eastern

Compare

HQL vs. RVT, NUV, USA, GAB, and STEW

Should you buy abrdn Life Sciences Investors stock or one of its competitors? MarketBeat compares abrdn Life Sciences Investors with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with abrdn Life Sciences Investors include Royce Small-Cap Trust (RVT), Nuveen Municipal Value Fund (NUV), Liberty All-Star Equity Fund (USA), Gabelli Equity Trust (GAB), and SRH Total Return Fund (STEW). These companies are all part of the "financial services" industry.

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

abrdn Life Sciences Investors (NYSE:HQL) and Royce Small-Cap Trust (NYSE:RVT) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Life Sciences Investors	$198.93M	3.05	N/A	N/A	N/A
Royce Small-Cap Trust	$88.69M	24.44	N/A	N/A	N/A

abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.2%. Royce Small-Cap Trust pays an annual dividend of $1.44 per share and has a dividend yield of 7.9%.

In the previous week, abrdn Life Sciences Investors had 3 more articles in the media than Royce Small-Cap Trust. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 1 mentions for Royce Small-Cap Trust. Royce Small-Cap Trust's average media sentiment score of 1.91 beat abrdn Life Sciences Investors' score of 1.07 indicating that Royce Small-Cap Trust is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Royce Small-Cap Trust	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Company	Net Margins	Return on Equity	Return on Assets
abrdn Life Sciences Investors	N/A	N/A	N/A
Royce Small-Cap Trust	N/A	N/A	N/A

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 25.6% of Royce Small-Cap Trust shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Comparatively, 0.1% of Royce Small-Cap Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

abrdn Life Sciences Investors has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market. Comparatively, Royce Small-Cap Trust has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market.

Summary

abrdn Life Sciences Investors beats Royce Small-Cap Trust on 5 of the 8 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Nuveen Municipal Value Fund (NYSE:NUV) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, abrdn Life Sciences Investors had 3 more articles in the media than Nuveen Municipal Value Fund. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 1 mentions for Nuveen Municipal Value Fund. Nuveen Municipal Value Fund's average media sentiment score of 1.21 beat abrdn Life Sciences Investors' score of 1.07 indicating that Nuveen Municipal Value Fund is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nuveen Municipal Value Fund	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuveen Municipal Value Fund	$104.26M	18.53	N/A	N/A	N/A
abrdn Life Sciences Investors	$198.93M	3.05	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Nuveen Municipal Value Fund	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

Nuveen Municipal Value Fund has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market.

22.5% of Nuveen Municipal Value Fund shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 1.0% of Nuveen Municipal Value Fund shares are held by insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Nuveen Municipal Value Fund pays an annual dividend of $0.19 per share and has a dividend yield of 2.1%. abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.2%.

Summary

abrdn Life Sciences Investors beats Nuveen Municipal Value Fund on 6 of the 8 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

Liberty All-Star Equity Fund (NYSE:USA) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

10.0% of Liberty All-Star Equity Fund shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 0.1% of Liberty All-Star Equity Fund shares are held by insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Liberty All-Star Equity Fund and Liberty All-Star Equity Fund both had 4 articles in the media. abrdn Life Sciences Investors' average media sentiment score of 1.07 beat Liberty All-Star Equity Fund's score of 0.71 indicating that abrdn Life Sciences Investors is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Liberty All-Star Equity Fund	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Liberty All-Star Equity Fund pays an annual dividend of $0.68 per share and has a dividend yield of 11.4%. abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.2%.

Liberty All-Star Equity Fund has a beta of 1.01, meaning that its stock price is 1% more volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Liberty All-Star Equity Fund	N/A	N/A	N/A	N/A	N/A
abrdn Life Sciences Investors	$198.93M	3.05	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Liberty All-Star Equity Fund	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

Summary

abrdn Life Sciences Investors beats Liberty All-Star Equity Fund on 4 of the 6 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Gabelli Equity Trust?

abrdn Life Sciences Investors (NYSE:HQL) and Gabelli Equity Trust (NYSE:GAB) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

In the previous week, abrdn Life Sciences Investors had 1 more articles in the media than Gabelli Equity Trust. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 3 mentions for Gabelli Equity Trust. abrdn Life Sciences Investors' average media sentiment score of 1.07 beat Gabelli Equity Trust's score of 0.49 indicating that abrdn Life Sciences Investors is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Gabelli Equity Trust	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

abrdn Life Sciences Investors has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, Gabelli Equity Trust has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Life Sciences Investors	$198.93M	3.05	N/A	N/A	N/A
Gabelli Equity Trust	$305.25M	5.81	N/A	N/A	N/A

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 7.2% of Gabelli Equity Trust shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Comparatively, 0.8% of Gabelli Equity Trust shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.2%. Gabelli Equity Trust pays an annual dividend of $0.60 per share and has a dividend yield of 10.5%.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Life Sciences Investors	N/A	N/A	N/A
Gabelli Equity Trust	N/A	N/A	N/A

Summary

abrdn Life Sciences Investors beats Gabelli Equity Trust on 5 of the 8 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to SRH Total Return Fund?

abrdn Life Sciences Investors (NYSE:HQL) and SRH Total Return Fund (NYSE:STEW) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

abrdn Life Sciences Investors has a beta of 0.75, indicating that its share price is 25% less volatile than the broader market. Comparatively, SRH Total Return Fund has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 10.2%. SRH Total Return Fund pays an annual dividend of $0.73 per share and has a dividend yield of 4.0%.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Life Sciences Investors	N/A	N/A	N/A
SRH Total Return Fund	N/A	N/A	N/A

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 15.6% of SRH Total Return Fund shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by insiders. Comparatively, 0.1% of SRH Total Return Fund shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, abrdn Life Sciences Investors had 2 more articles in the media than SRH Total Return Fund. MarketBeat recorded 4 mentions for abrdn Life Sciences Investors and 2 mentions for SRH Total Return Fund. SRH Total Return Fund's average media sentiment score of 1.43 beat abrdn Life Sciences Investors' score of 1.07 indicating that SRH Total Return Fund is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Life Sciences Investors	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SRH Total Return Fund	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Life Sciences Investors	$198.93M	3.05	N/A	N/A	N/A
SRH Total Return Fund	N/A	N/A	N/A	N/A	N/A

Summary

abrdn Life Sciences Investors beats SRH Total Return Fund on 5 of the 7 factors compared between the two stocks.

Get abrdn Life Sciences Investors News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQL vs. The Competition

Export

Metric	abrdn Life Sciences Investors	FIN Industry	Finance Sector	NYSE Exchange
Market Cap	$606.34M	$4.83B	$14.42B	$23.43B
Dividend Yield	10.26%	6.84%	5.70%	4.01%
P/E Ratio	N/A	0.02	20.66	31.25
Price / Sales	3.05	24.42	44.79	19.88
Price / Cash	N/A	4.79	19.32	24.90
Price / Book	N/A	3.07	2.27	4.79
Net Income	N/A	$388.27M	$1.13B	$1.07B
7 Day Performance	-3.28%	0.11%	1.35%	1.14%
1 Month Performance	16.31%	0.15%	1.64%	0.56%
1 Year Performance	53.98%	11.69%	14.05%	18.71%

abrdn Life Sciences Investors Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQL abrdn Life Sciences Investors	N/A	$19.94 +0.1%	N/A	+51.5%	$606.34M	$198.93M	N/A	N/A	News Coverage Positive News Short Interest Decrease
RVT Royce Small-Cap Trust	N/A	$17.88 -1.6%	N/A	+17.5%	$2.14B	N/A	N/A	50	Positive News
NUV Nuveen Municipal Value Fund	N/A	$9.17 -0.5%	N/A	+6.0%	$1.93B	N/A	N/A	640	News Coverage Positive News
USA Liberty All-Star Equity Fund	N/A	$5.85 -0.6%	N/A	-13.1%	$1.80B	N/A	N/A	N/A	News Coverage Short Interest Increase
GAB Gabelli Equity Trust	N/A	$5.62 -0.4%	N/A	-3.7%	$1.75B	N/A	N/A	N/A	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HQL) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

abrdn Life Sciences Investors (HQL) Competitors

HQL vs. RVT, NUV, USA, GAB, and STEW

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Summary

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Summary

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

Summary

How does abrdn Life Sciences Investors compare to Gabelli Equity Trust?

Summary

How does abrdn Life Sciences Investors compare to SRH Total Return Fund?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQL vs. The Competition

abrdn Life Sciences Investors Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

abrdn Life Sciences Investors (HQL) Competitors

HQL vs. RVT, NUV, USA, GAB, and STEW

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Which has higher earnings & valuation, HQL or RVT?

Is HQL or RVT a better dividend stock?

Does the media refer more to HQL or RVT?

Is HQL or RVT more profitable?

Do institutionals & insiders hold more shares of HQL or RVT?

Which has more risk & volatility, HQL or RVT?

Summary

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Does the media prefer NUV or HQL?

Which has preferable valuation and earnings, NUV or HQL?

Is NUV or HQL more profitable?

Which has more volatility and risk, NUV or HQL?

Do institutionals and insiders believe in NUV or HQL?

Is NUV or HQL a better dividend stock?

Summary

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

Do insiders & institutionals believe in USA or HQL?

Does the media refer more to USA or HQL?

Is USA or HQL a better dividend stock?

Which has more volatility & risk, USA or HQL?

Which has higher valuation & earnings, USA or HQL?

Is USA or HQL more profitable?

Summary

How does abrdn Life Sciences Investors compare to Gabelli Equity Trust?

Does the media favor HQL or GAB?

Which has more risk & volatility, HQL or GAB?

Which has better valuation & earnings, HQL or GAB?

Do insiders & institutionals have more ownership in HQL or GAB?

Is HQL or GAB a better dividend stock?

Is HQL or GAB more profitable?

Summary

How does abrdn Life Sciences Investors compare to SRH Total Return Fund?

Which has more volatility and risk, HQL or STEW?

Is HQL or STEW a better dividend stock?

Is HQL or STEW more profitable?

Do institutionals & insiders have more ownership in HQL or STEW?

Does the media prefer HQL or STEW?

Which has better valuation & earnings, HQL or STEW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQL vs. The Competition

abrdn Life Sciences Investors Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools